Evidence map›Paper›PMID 38099618›Full record

ArticleMicrobiology spectrum2024

Axel B Janssen, Vincent de Bakker, Rieza Aprianto, Vincent Trebosc, Christian Kemmer, Michel Pieren, Jan-Willem Veening

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Co-evolution of resistance and virulence inFrontiers in cellular and infection microbiology · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Axel B JanssenDepartment of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne , Lausanne, Switzerland.ORCID 0000-0002-9865-447X
Vincent de BakkerDepartment of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne , Lausanne, Switzerland.ORCID 0000-0003-1019-3558
Rieza ApriantoMolecular Genetics Group, University of Groningen, Groningen Biomolecular Sciences and Biotechnology Institute, Centre for Synthetic Biology , Groningen, the Netherlands.ORCID 0000-0003-2479-7352
Vincent TreboscBioVersys AG , Basel, Switzerland.ORCID 0000-0002-8961-1371
Christian KemmerBioVersys AG , Basel, Switzerland.
Michel PierenBioVersys AG , Basel, Switzerland.ORCID 0000-0001-7896-254X
Jan-Willem VeeningDepartment of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne , Lausanne, Switzerland.ORCID 0000-0002-3162-6634

Funding

Swiss National Science Foundation 310030_192517Swiss National Science Foundation 310030_200792Swiss National Science Foundation 51NF40_180541Swiss National Science Foundation TMPFP3_210202
6 · The paper itself

Abstract

importanceBacteria use two-component regulatory systems (TCSs) to adapt to changes in their environment by changing their gene expression. In this study, we show that the EnvZ/OmpR TCS of the clinically relevant opportunistic pathogen

Indexed as

Bacterial ProteinsVirulence FactorsGene Expression Regulation, BacterialKlebsiella pneumoniaeLungBacterial ProteinsVirulence Factorsdual RNA-seqepithelial cellshost-pathogen interactioninfectionKlebsiella pneumoniaeOmpR

Identifiers

PMID38099618
PMCPMC10783089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.